Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Isolated congenital megalocornea is a genetic, non-syndromic developmental defect of the anterior eye segment characterized by bilateral enlargement of the corneal diameter (>12.5 mm) and a deep anterior eye chamber, without an elevation in intraocular pressure. It can manifest with mild to moderate myopia as well as photophobia and iridodonesis (due to iris hypoplasia). Associated complications include lens dislocation, retinal detachment, presenile cataract development, and secondary glaucoma.
Features include always present findings: Megalocornea, Iris transillumination defect, and Reduced visual acuity; and common findings: Corneal arcus. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 7 | Mosaic corneal dystrophy, Lens subluxation, Retinal detachment |
Age of onset: at birth.
CHRDL1 encodes chordin like 1 (456 aa). Antagonizes the function of BMP4 by binding to it and preventing its interaction with receptors. Alters the fate commitment of neural stem cells from gliogenesis to neurogenesis. Highest expression in Nerve Tibial (195.3 TPM) and Adipose Subcutaneous (180.5 TPM).
Isolated congenital megalocornea is associated with mutations in the CHRDL1 gene on chromosome X.
CHRDL1 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for CHRDL1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for isolated congenital megalocornea has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 common feature.
No clinical trials have been registered for isolated congenital megalocornea.
16 publications have been identified in PubMed for isolated congenital megalocornea. Research spans Case Report / Case Series (67%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 67% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 4:35 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
3 |
20% |
Testing and diagnosis research | 1 | 7% |
Laboratory research | 1 | 7% |
Zhu D (2026). [PMID: 41953647](https://pubmed.ncbi.nlm.nih.gov/41953647/). *Mol Vis*. [Basic Science / Preclinical]
Goel P (2026). [PMID: 41930028](https://pubmed.ncbi.nlm.nih.gov/41930028/). *Oman J Ophthalmol*. [Case Report / Case Series]
Ninet L (2026). [PMID: 41654108](https://pubmed.ncbi.nlm.nih.gov/41654108/). *J AAPOS*. [Case Report / Case Series]
Plotsker NM (2026). [PMID: 41807268](https://pubmed.ncbi.nlm.nih.gov/41807268/). *Vet Ophthalmol*. [Case Report / Case Series]
Pawar N (2026). [PMID: 41703929](https://pubmed.ncbi.nlm.nih.gov/41703929/). *Ophthalmic Genet*. [Case Report / Case Series]
Stopak W (2026). [PMID: 40717626](https://pubmed.ncbi.nlm.nih.gov/40717626/). *J Child Neurol*. [Review / Meta-Analysis]
Ismedon M (2026). [PMID: 41911953](https://pubmed.ncbi.nlm.nih.gov/41911953/). *Ophthalmic Genet*. [Case Report / Case Series]
Vaccaro S (2025). [PMID: 40013468](https://pubmed.ncbi.nlm.nih.gov/40013468/). *Acta Ophthalmol*. [Review / Meta-Analysis]
Elmakhzen B (2025). [PMID: 40978814](https://pubmed.ncbi.nlm.nih.gov/40978814/). *Cureus*. [Case Report / Case Series]
Sinha R (2025). [PMID: 39728689](https://pubmed.ncbi.nlm.nih.gov/39728689/). *Indian J Ophthalmol*. [Case Report / Case Series]